How much it improved the firmness of my skin I'm not sure - i need to give it longer than a week
Albiglutide is another once-weekly GLP-1 agent that was previously used for diabetes treatment but has been withdrawn from many markets and is no longer commonly prescribed
In 2006, diabetes was the seventh leading cause of death, and it remains the leading cause of new cases of blindness and kidney failure
Yes, if there have been no modifications to your diet, exercise, & lifestyle Sources: LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept ScienceDirect TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Pemvidutide graph: The novel GIP, GLP1 and glucagon receptor agonist Retatrutide delays gastric emptying Urva 2023 Diabetes, Obesity and Metabolism Hemodynamic Effects of Glucagon: A Literature Review | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic Day 1 Video 4: GLUCAGON ACTION THE KNOWN UNKNOWNS by Daniel Drucker
The "CJC" prefix references the company name